Egfr-mutant Glioblastoma
📧 Sign up to get email alerts when something new happens for Egfr-mutant Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells [Phase 1]
Phase 1 clinical trial update for E-SYNC, a CAR T cell therapy using a synNotch EGFRvIII trigger to drive anti-EphA2/IL-13Ralpha2 CAR expres…